Stem Cell Assurance announces $1M agreement with private funding source

Sep 3 2010

Stem Cell Assurance, Inc. (Pink Sheets:SCLZ), a leader in stem cell collection and storage services for personal applications ranging from breast augmentation and facial rejuvenation procedures to Stem Cellutrition™ (www.stemcellutrition.com) skincare products, today announced a $1M agreement with a private funding source. This source will provide consulting services as it relates to securing loans, letters of credit, and/or debt based facilities for the acquisition of equipment necessary for the cryopreservation of adipose tissue, umbilical cord blood stem cells and peripheral blood stem cells. In addition to the funding referenced above, the Company is in negotiations with this source for an additional $1.5M as needed.

“This agreement between Stem Cell Assurance and our funding source enables the Company to fulfill a critical stage in the development of the Company's long term goals”

"This agreement between Stem Cell Assurance and our funding source enables the Company to fulfill a critical stage in the development of the Company's long term goals," said Stem Cell Assurance's CFO, Richard Proodian. (www.stemcellassurance.com).

Stem Cell Assurance's cryopreservation facility will offer multiple storage processes and units, enabling the Company to offer a variety of options for clients, and uniquely positioning Stem Cell Assurance to offer a wide variety of choices for patients. An adult autologous stem cell culture lab will also be built in this facility. Adult stem cells will be obtained from patients' own fat or blood and are not derived from embryonic cells. In addition, the funding will enable Stem Cell Assurance to begin its research model using stem cells in treating diabetes.

Stem Cell Assurance will also open twelve additional liposuction collection facilities identical to the existing center in Boca Raton under the subsidiary "Lipo Rejuvenation Centers, Inc." The Company is projecting a minimum of eight (8) procedures per month, per center. This will be enhanced by airing 30 second television and radio commercials to promote the centers.

Stem Cell Assurance provides its clients with stem cell collection and storage services for personal use in medical stem cell therapies and as bio-insurance for future stem cell applications and disease treatments. The Company also provides genetic profile testing that can determine if a person has a genetic condition or predisposition to a certain disease in the future. The Company continues to probe other areas of discovery including medical therapies in an effort to develop improved results for its customers.